She was referred to our hospital and diagnosed with SMA type I, with homo deletions of SMN1 exons 7 and 8, and two copies of the SMN2. She had received nusinersen twice and OA was administered at 7 months of age. This evidence concerns the gene SMN2 and spinal muscular atrophy, type 1.